BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kasiske BL, Gaston RS, Gourishankar S, Halloran PF, Matas AJ, Jeffery J, Rush D. Long-term deterioration of kidney allograft function. Am J Transplant. 2005;5:1405-1414. [PMID: 15888048 DOI: 10.1111/j.1600-6143.2005.00853.x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 76] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Günay E, Çelebi T, Şen S, Aşcı G, Sarsik Kumbaraci B, Gökalp C, Yılmaz M, Töz H. Investigation of the Factors Affecting Allograft Kidney Functions: Results of 10 Years. Transplant Proc 2019;51:1082-5. [PMID: 31101175 DOI: 10.1016/j.transproceed.2019.02.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Kasiske BL, Israni AK, Snyder JJ, Skeans MA. The relationship between kidney function and long-term graft survival after kidney transplant. Am J Kidney Dis. 2011;57:466-475. [PMID: 21257243 DOI: 10.1053/j.ajkd.2010.10.054] [Cited by in Crossref: 86] [Cited by in F6Publishing: 76] [Article Influence: 7.8] [Reference Citation Analysis]
3 Mengel M, Gwinner W, Schwarz A, Bajeski R, Franz I, Bröcker V, Becker T, Neipp M, Klempnauer J, Haller H. Infiltrates in protocol biopsies from renal allografts. Am J Transplant. 2007;7:356-365. [PMID: 17283485 DOI: 10.1111/j.1600-6143.2006.01635.x] [Cited by in Crossref: 148] [Cited by in F6Publishing: 126] [Article Influence: 9.9] [Reference Citation Analysis]
4 Kamoun M. Mechanisms of chronic allograft dysfunction. Ther Drug Monit 2006;28:14-8. [PMID: 16418687 DOI: 10.1097/01.ftd.0000194499.32398.32] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
5 Gaber LW, Knight RJ, Patel SJ. A surgeons' guide to renal transplant immunopathology, immunology, and immunosuppression. Surg Clin North Am 2013;93:1293-307. [PMID: 24206852 DOI: 10.1016/j.suc.2013.09.002] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Mccaughan JA, Courtney AE, Maxwell AP. Estimated Glomerular Filtration Rate Decline as a Predictor of Dialysis in Kidney Transplant Recipients. Am J Nephrol 2014;39:297-305. [DOI: 10.1159/000360426] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
7 Marcén R, Morales JM, Fernández-Rodriguez A, Capdevila L, Pallardó L, Plaza JJ, Cubero JJ, Puig JM, Sanchez-Fructuoso A, Arias M, Alperovich G, Serón D. Long-term graft function changes in kidney transplant recipients. NDT Plus 2010;3:ii2-8. [PMID: 20508857 DOI: 10.1093/ndtplus/sfq063] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
8 Randhawa P, Mannon RB. A case of late kidney allograft failure: a clinical pathological conference from American Society of Nephrology Kidney Week 2011. Clin J Am Soc Nephrol 2012;7:1884-9. [PMID: 22859745 DOI: 10.2215/CJN.04920512] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Seiler M, Brabcova I, Viklicky O, Hribova P, Rosenberger C, Pratschke J, Lodererova A, Matz M, Schönemann C, Reinke P, Volk H, Kotsch K. Heightened Expression of the Cytotoxicity Receptor NKG2D Correlates with Acute and Chronic Nephropathy After Kidney Transplantation. Am J Transplant 2007;7:423-33. [DOI: 10.1111/j.1600-6143.2006.01625.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
10 Kaplan B. Overcoming Barriers to Long-Term Graft Survival. American Journal of Kidney Diseases 2006;47:S52-64. [DOI: 10.1053/j.ajkd.2005.12.044] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
11 Moranne O, Maillard N, Fafin C, Thibaudin L, Alamartine E, Mariat C. Rate of renal graft function decline after one year is a strong predictor of all-cause mortality. Am J Transplant 2013;13:695-706. [PMID: 23311466 DOI: 10.1111/ajt.12053] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
12 Chaudhry A, Sosin M, Bojovic B, Christy MR, Drachenberg CB, Rodriguez ED. Defining the Role of Skin and Mucosal Biopsy in Facial Allotransplantation: A 2-Year Review and Analysis of Histology. Plastic and Reconstructive Surgery 2015;136:559-67. [DOI: 10.1097/prs.0000000000001529] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.9] [Reference Citation Analysis]
13 Ingsathit A, Avihingsanon Y, Rattanasiri S, Premasathian N, Pongskul C, Jittikanont S, Sumethkul V. Different Etiologies of Graft Loss and Death in Asian Kidney Transplant Recipients: A Report From Thai Transplant Registry. Transplantation Proceedings 2010;42:4014-6. [DOI: 10.1016/j.transproceed.2010.09.061] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
14 Gaston RS. Current and evolving immunosuppressive regimens in kidney transplantation. Am J Kidney Dis. 2006;47:S3-21. [PMID: 16567239 DOI: 10.1053/j.ajkd.2005.12.047] [Cited by in Crossref: 37] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
15 Fonseca I, Almeida M, Martins L, Santos J, Dias L, Lobato L, Henriques A, Mendonça D. First-Year Renal Function Predicts Long-Term Renal Allograft Loss. Transplantation Proceedings 2011;43:106-12. [DOI: 10.1016/j.transproceed.2010.12.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
16 Abbud-filho M, Adams PL, Alberú J, Cardella C, Chapman J, Cochat P, Cosio F, Danovitch G, Davis C, Gaston RS, Humar A, Hunsicker LG, Josephson MA, Kasiske B, Kirste G, Leichtman A, Munn S, Obrador GT, Tibell A, Wadström J, Zeier M, Delmonico FL. A Report of the Lisbon Conference on the Care of the Kidney Transplant Recipient. Transplantation 2007;83:S1-S22. [DOI: 10.1097/01.tp.0000260765.41275.e2] [Cited by in Crossref: 76] [Cited by in F6Publishing: 52] [Article Influence: 5.1] [Reference Citation Analysis]
17 Mekeel K, Meier-kriesche H, Kaplan B. Are we making progress in kidney transplantation? Current Opinion in Organ Transplantation 2006;11:1-6. [DOI: 10.1097/01.mot.0000203881.02687.51] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Townamchai N, Praditpornsilpa K, Eiam-ong S. Endothelial Progenitor Cells in Asian Kidney Transplant Patients. Transplantation Proceedings 2010;42:1690-4. [DOI: 10.1016/j.transproceed.2010.01.063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
19 Townamchai N, Eiam-Ong S. Biomarkers in kidney transplantation: From bench to bedside. World J Nephrol 2015; 4(5): 487-491 [PMID: 26558185 DOI: 10.5527/wjn.v4.i5.487] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
20 Tang IY, Meier-Kriesche HU, Kaplan B. Immunosuppressive strategies to improve outcomes of kidney transplantation. Semin Nephrol 2007;27:377-92. [PMID: 17616271 DOI: 10.1016/j.semnephrol.2007.03.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
21 Townamchai N, Safa K, Chandraker A. Immunologic monitoring in kidney transplant recipients. Kidney Res Clin Pract 2013;32:52-61. [PMID: 26877913 DOI: 10.1016/j.krcp.2013.04.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
22 Paraskevas S, Kandaswamy R, Humar A, Gillingham KJ, Gruessner RW, Payne WD, Najarian JS, Sutherland DE, Matas AJ. Risk factors for rising creatinine in renal allografts with 1 and 3 yr survival. Clin Transplant 2006;20:667-72. [PMID: 17100713 DOI: 10.1111/j.1399-0012.2006.00566.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
23 Mortensen LA, Thiesson HC, Tougaard B, Egfjord M, Fischer ASL, Bistrup C. The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity: a multicenter randomized, double-blind, clinical trial (the SPIREN trial). BMC Nephrol 2018;19:105. [PMID: 29724188 DOI: 10.1186/s12882-018-0885-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
24 Zukowski M, Kotfis K, Kaczmarczyk M, Biernawska J, Szydłowski L, Zukowska A, Sulikowski T, Sierocka A, Bohatyrewicz R. Influence of selected factors on long-term kidney graft survival--a multivariable analysis. Transplant Proc 2014;46:2696-8. [PMID: 25380897 DOI: 10.1016/j.transproceed.2014.08.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
25 Andrade-Sierra J, Rojas-Campos E, Cardona-Muñoz E, Evangelista-Carrillo LA, Gómez-Navarro B, González-Espinoza E, Lugo-Lopez O, Cerrillos-Gutiérrez JI, Medina-Pérez M, Jalomo-Martínez B, Nieves-Hernández JJ, Sandoval M, Abundis-Jiménez JR, Ramírez-Robles JN, Villanueva-Pérez MA, Monteón-Ramos F, Cueto-Manzano AM. Early Steroid Withdrawal in Recipients of a Kidney Transplant From a Living Donor: Experience of a Single Mexican Center. Transplant Proc 2016;48:42-9. [PMID: 26915841 DOI: 10.1016/j.transproceed.2015.12.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
26 Stevens RB, Foster KW, Miles CD, Kalil AC, Florescu DF, Sandoz JP, Rigley TH, Malik T, Wrenshall LE. A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology. PLoS One 2015;10:e0139247. [PMID: 26465152 DOI: 10.1371/journal.pone.0139247] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
27 Srinivas TR, Flechner SM, Poggio ED, Askar M, Goldfarb DA, Navaneethan SD, Schold JD. Glomerular Filtration Rate Slopes Have Significantly Improved Among Renal Transplants in the United States. Transplantation 2010;90:1499-505. [DOI: 10.1097/tp.0b013e3182003dda] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
28 Gill JS. Potential Advantages and Limitations of Applying the Chronic Kidney Disease Classification to Kidney Transplant Recipients. Am J Transplant 2006;6:2821-6. [DOI: 10.1111/j.1600-6143.2006.01556.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
29 Stribos EG, van Werkhoven MB, Poppelaars F, van Goor H, Olinga P, van Son WJ, Damman J, Seelen MA. Renal expression of Toll-like receptor 2 and 4: Dynamics in human allograft injury and comparison to rodents. Molecular Immunology 2015;64:82-9. [DOI: 10.1016/j.molimm.2014.11.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
30 Weitz M, Laube GF, Schmidt M, Krupka K, Murer L, Müller D, Hoppe B, Büscher A, König J, Pohl M, Jungraithmayr T, Thiel F, Billing H, Grenda R, Rubik J, Kaabak MM, Yalcinkaya F, Topaloglu R, Webb N, Dello Strologo L, Pape L, Nadalin S, Tönshoff B. Outcome of renal transplantation in small infants: a match-controlled analysis. Pediatr Nephrol 2018;33:1057-68. [DOI: 10.1007/s00467-018-3895-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
31 Katsuma A, Yamakawa T, Nakada Y, Yamamoto I, Yokoo T. Histopathological findings in transplanted kidneys. Ren Replace Ther 2017;3. [DOI: 10.1186/s41100-016-0089-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
32 Park WD, Griffin MD, Cornell LD, Cosio FG, Stegall MD. Fibrosis with inflammation at one year predicts transplant functional decline. J Am Soc Nephrol 2010;21:1987-97. [PMID: 20813870 DOI: 10.1681/ASN.2010010049] [Cited by in Crossref: 155] [Cited by in F6Publishing: 63] [Article Influence: 12.9] [Reference Citation Analysis]
33 Kotfis K, Kaczmarczyk M, Biernawska J, Szydłowski L, Zukowska A, Szliżewska K, Zegan-Barańska M, Bohatyrewicz R, Zukowski M. Influence of the hemodynamic status of multiorgan donors on long-term kidney graft survival--a multivariable analysis. Transplant Proc 2014;46:2562-4. [PMID: 25380866 DOI: 10.1016/j.transproceed.2014.08.017] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Hernández D, Rufino M, González-posada JM, Torres A, Pascual J. Surrogate end points for graft failure and mortality in kidney transplantation. Transplantation Reviews 2007;21:97-106. [DOI: 10.1016/j.trre.2007.03.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
35 Imamović G, Zerem E, Osmanović E. Kidney graft outcomes in living-related transplantation have improved with substitution of basiliximab and mycophenolate mofetil for antithymocyte globulin and azathioprine: a single center retrospective cohort study. Eur J Intern Med 2010;21:524-9. [PMID: 21111938 DOI: 10.1016/j.ejim.2010.09.012] [Reference Citation Analysis]
36 Ferro CJ, Hodson J, Moore J, Mcclure M, Tomson CRV, Nightingale P, Borrows R. Bayesian Analysis of Glomerular Filtration Rate Trajectories in Kidney Transplant Recipients: A Pilot Study. Transplantation 2015;99:533-9. [DOI: 10.1097/tp.0000000000000377] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
37 Zwiech R, Bruzda-zwiech A. Does oral health contribute to post-transplant complications in kidney allograft recipients? Acta Odontologica Scandinavica 2012;71:756-63. [DOI: 10.3109/00016357.2012.715203] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
38 Zukowska A, Kotfis K, Kaczmarczyk M, Biernawska J, Szydłowski L, Sulikowski T, Sierocka A, Pawlus J, Bohatyrewicz R, Zukowski M. Impact of graft infection on long-term survival after kidney transplant. Transplant Proc 2014;46:2752-4. [PMID: 25380909 DOI: 10.1016/j.transproceed.2014.08.018] [Reference Citation Analysis]
39 Pauly RP, Asad RA, Hanley JA, Pierratos A, Zaltzman J, Chery A, Chan CT. Long-term clinical outcomes of nocturnal hemodialysis patients compared with conventional hemodialysis patients post-renal transplantation. Clinical Transplantation 2009;23:47-55. [DOI: 10.1111/j.1399-0012.2008.00899.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
40 Djamali A, Samaniego M, Muth B, Muehrer R, Hofmann RM, Pirsch J, Howard A, Mourad G, Becker BN. Medical Care of Kidney Transplant Recipients after the First Posttransplant Year. CJASN 2006;1:623-40. [DOI: 10.2215/cjn.01371005] [Cited by in Crossref: 58] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
41 Stevens RB, Foster KW, Miles CD, Lane JT, Kalil AC, Florescu DF, Sandoz JP, Rigley TH, Nielsen KJ, Skorupa JY, Kellogg AM, Malik T, Wrenshall LE. A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes. Transplantation 2015;99:197-209. [PMID: 25083614 DOI: 10.1097/TP.0000000000000250] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
42 Gourishankar S, Leduc R, Connett J, Cecka JM, Cosio F, Fieberg A, Gaston R, Halloran P, Hunsicker L, Kasiske B, Rush D, Grande J, Mannon R, Matas A. Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study. Am J Transplant 2010;10:324-30. [PMID: 20055809 DOI: 10.1111/j.1600-6143.2009.02954.x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 77] [Article Influence: 8.0] [Reference Citation Analysis]
43 Nevins TE, Thomas W. Quantitative patterns of azathioprine adherence after renal transplantation. Transplantation 2009;87:711-8. [PMID: 19295316 DOI: 10.1097/TP.0b013e318195c3d5] [Cited by in Crossref: 62] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
44 Wiebe C, Gibson IW, Blydt-Hansen TD, Pochinco D, Birk PE, Ho J, Karpinski M, Goldberg A, Storsley L, Rush DN, Nickerson PW. Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody. Am J Transplant 2015;15:2921-30. [PMID: 26096305 DOI: 10.1111/ajt.13347] [Cited by in Crossref: 212] [Cited by in F6Publishing: 187] [Article Influence: 30.3] [Reference Citation Analysis]
45 Kobayashi A, Yamamoto I, Ito S, Akioka Y, Yamamoto H, Teraoka S, Hattori M, Tanabe K, Hosoya T, Yamaguchi Y. Medullary ray injury in renal allografts: Medullary ray injury. Pathology International 2010;60:744-9. [DOI: 10.1111/j.1440-1827.2010.02593.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
46 Mas VR, Mas LA, Archer KJ, Yanek K, King AL, Gibney EM, Cotterell A, Fisher RA, Posner M, Maluf DG. Evaluation of gene panel mRNAs in urine samples of kidney transplant recipients as a non-invasive tool of graft function. Mol Med 2007;13:315-24. [PMID: 17622313 DOI: 10.2119/2007–00017.Mas] [Cited by in Crossref: 21] [Article Influence: 1.4] [Reference Citation Analysis]
47 Alexander SI, Fletcher JT, Nankivell B. Chronic allograft nephropathy in paediatric renal transplantation. Pediatr Nephrol 2007;22:17-23. [PMID: 16944214 DOI: 10.1007/s00467-006-0219-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
48 Ballet C, Giral M, Ashton-chess J, Renaudin K, Brouard S, Soulillou J. Chronic rejection of human kidney allografts. Expert Review of Clinical Immunology 2014;2:393-402. [DOI: 10.1586/1744666x.2.3.393] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
49 Geddes CC, Mcmanus SK, Koteeswaran S, Baxter GM. Long-term outcome of transplant renal artery stenosis managed conservatively or by radiological intervention: Management of transplant renal artery stenosis. Clinical Transplantation 2008;22:572-8. [DOI: 10.1111/j.1399-0012.2008.00826.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
50 Samaan F, Requião-moura L, Pinheiro H, Ozaki K, Saraiva Câmara N, Pacheco-silva A. Prevalence and Progression of Chronic Kidney Disease after Renal Transplantation. Transplantation Proceedings 2011;43:2587-91. [DOI: 10.1016/j.transproceed.2011.05.055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
51 Olbricht CJ. Why do we need biomarkers in solid organ transplantation. Clinica Chimica Acta 2012;413:1310-1. [DOI: 10.1016/j.cca.2012.04.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
52 Crespo M, Heidt S, Redondo D, Pascual J. Monitoring B cell subsets and alloreactivity in kidney transplantation. Transplant Rev (Orlando) 2015;29:45-52. [PMID: 25867605 DOI: 10.1016/j.trre.2015.02.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
53 Ucar ZA, Sinangil A, Koc Y, Barlas S, Abouzahir S, Ecder ST, Akin EB. Clinical Prognosis of Renal Retransplant Patients: A Single-Center Experience. Transplant Proc 2019;51:2274-8. [PMID: 31474292 DOI: 10.1016/j.transproceed.2019.03.053] [Reference Citation Analysis]
54 Sola E, Gonzalez-molina M, Cabello M, Burgos D, Ramos J, Gutierrez C, Lopez V, Soler J, de la Vega E, Hernandez D. Long-Term Improvement of Deceased Donor Renal Allograft Survival Since 1996: A Single Transplant Center Study. Transplantation 2010;89:714-20. [DOI: 10.1097/tp.0b013e3181c892dd] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
55 Hashem AM, Djohan R, Bernard S, Hendrickson M, Schwarz G, Gharb BB, Rampazzo A, Hoffman GS, Doumit G, Bergfeld W, Zins JE, Siemionow M, Papay F, Gastman B. Face Transplantation for Granulomatosis With Polyangiitis (Wegener Granulomatosis): Technical Considerations, Immunological Aspects, and 3-Year Posttransplant Outcome. Ann Plast Surg 2019;82:320-9. [DOI: 10.1097/sap.0000000000001735] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
56 Tojimbara T, Fuchinoue S, Iwadoh K, Koyama I, Sannomiya A, Kato Y, Nanmoku K, Kai K, Nakajima I, Toma H. Improved outcomes of renal transplantation from cardiac death donors: a 30-year single center experience. Am J Transplant. 2007;7:609-617. [PMID: 17217439 DOI: 10.1111/j.1600-6143.2007.01664.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 3.3] [Reference Citation Analysis]
57 Rodrigo E, Fernández-fresnedo G, Castañeda O, Arias M. Estimation of renal function in adult kidney transplant recipients by equations. Transplantation Reviews 2007;21:1-16. [DOI: 10.1016/j.trre.2007.01.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
58 Levy AR, Briggs AH, Johnston K, MacLean JR, Yuan Y, L'Italien GJ, Kalsekar A, Schnitzler MA. Projecting long-term graft and patient survival after transplantation. Value Health 2014;17:254-60. [PMID: 24636384 DOI: 10.1016/j.jval.2014.01.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
59 van de Wetering J, Koumoutsakos P, Peeters A, van der Mast BJ, de Kuiper P, IJzermans JN, Weimar W, Baan CC. Discontinuation of calcineurin inhibitors treatment allows the development of FOXP3+ regulatory T-cells in patients after kidney transplantation. Clin Transplant. 2011;25:40-46. [PMID: 20636406 DOI: 10.1111/j.1399-0012.2010.01311.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
60 Gaston RS, Fieberg A, Hunsicker L, Kasiske BL, Leduc R, Cosio FG, Gourishankar S, Grande J, Mannon RB, Rush D, Cecka JM, Connett J, Matas AJ. Late graft failure after kidney transplantation as the consequence of late versus early events. Am J Transplant 2018;18:1158-67. [DOI: 10.1111/ajt.14590] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
61 Trailin AV, Pleten MV, Ostapenko TI, Iefimenko NF, Nikonenko OS. High Serum Level of β2-Microglobulin in Late Posttransplant Period Predicts Subsequent Decline in Kidney Allograft Function: A Preliminary Study. Dis Markers 2015;2015:562580. [PMID: 26633915 DOI: 10.1155/2015/562580] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
62 Chang SH, Russ GR, Chadban SJ, Campbell SB, McDonald SP. Trends in kidney transplantation in Australia and New Zealand, 1993-2004. Transplantation 2007;84:611-8. [PMID: 17876274 DOI: 10.1097/01.tp.0000280553.23898.ef] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 3.5] [Reference Citation Analysis]
63 Macdonald AS. Use of mTOR inhibitors in human organ transplantation. Expert Review of Clinical Immunology 2014;3:423-36. [DOI: 10.1586/1744666x.3.3.423] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
64 Hall IE, Schröppel B, Doshi MD, Ficek J, Weng FL, Hasz RD, Thiessen-Philbrook H, Reese PP, Parikh CR. Associations of deceased donor kidney injury with kidney discard and function after transplantation. Am J Transplant. 2015;15:1623-1631. [PMID: 25762442 DOI: 10.1111/ajt.13144] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 10.1] [Reference Citation Analysis]
65 Mayne TJ, Nordyke RJ, Schold JD, Weir MR, Mohan S. Defining a minimal clinically meaningful difference in 12-month estimated glomerular filtration rate for clinical trials in deceased donor kidney transplantation. Clin Transplant 2021;35:e14326. [PMID: 33896052 DOI: 10.1111/ctr.14326] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Burgos D, Gonzalez-molina M, Ruiz-esteban P, Gutierrez C, Rodriguez M, Fuentes L, Blanca L, Hernandez D. Rate of Long-Term Graft Loss Has Fallen Among Kidney Transplants From Cadaveric Donors. Transplantation Proceedings 2012;44:2558-60. [DOI: 10.1016/j.transproceed.2012.09.101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
67 Lantieri L, Meningaud JP, Grimbert P, Bellivier F, Lefaucheur JP, Ortonne N, Benjoar MD, Lang P, Wolkenstein P. Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study. Lancet. 2008;372:639-645. [PMID: 18722868 DOI: 10.1016/S0140-6736(08)61277-5] [Cited by in Crossref: 228] [Cited by in F6Publishing: 31] [Article Influence: 16.3] [Reference Citation Analysis]
68 Curtis JJ. Protocol Biopsy: Today’s Fine-Needle Aspiration Biopsy? Transplantation 2007;84:677-8. [DOI: 10.1097/01.tp.0000281900.71535.40] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
69 Townamchai N, Avihingsanon Y, Praditpornsilpa K, Tungsanga K, Eiam-ong S. De Novo Sirolimus-Based Regimen in Thai Renal Transplant Recipients. Transplantation Proceedings 2008;40:2206-8. [DOI: 10.1016/j.transproceed.2008.07.070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
70 Choi HY, Huh KH, Lee JG, Song MK, Kim MS, Kim YS, Kim BS. Variability of the Estimated Glomerular Filtration Rate in the First Year after Kidney Transplantation Is an Independent Risk Factor for Poor Renal Allograft Outcomes: A Retrospective Cohort Study. PLoS One 2016;11:e0168337. [PMID: 27973553 DOI: 10.1371/journal.pone.0168337] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
71 Ozaki KS, Kimura S, Nalesnik MA, Sico RM, Zhang M, Ueki S, Ross MA, Stolz DB, Murase N. The loss of renal dendritic cells and activation of host adaptive immunity are long-term effects of ischemia/reperfusion injury following syngeneic kidney transplantation. Kidney Int 2012;81:1015-25. [PMID: 22278023 DOI: 10.1038/ki.2011.458] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
72 Ingsathit A, Kantachuvesiri S, Rattanasiri S, Avihingsanon Y, Premasathian N, Pongskul C, Jittikanont S, Lumpaopong A, Sumethkul V. Long-term Outcome of Kidney Retransplantation in Comparison With First Kidney Transplantation: A Report From the Thai Transplantation Registry. Transplantation Proceedings 2013;45:1427-30. [DOI: 10.1016/j.transproceed.2012.08.029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
73 Webster AC, Lee VW, Chapman JR, Craig JC. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients. Cochrane Database Syst Rev 2006;:CD004290. [PMID: 16625599 DOI: 10.1002/14651858.CD004290.pub2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
74 Higgins RS, Fishman JA. Disparities in solid organ transplantation for ethnic minorities: facts and solutions. Am J Transplant 2006;6:2556-62. [PMID: 16952299 DOI: 10.1111/j.1600-6143.2006.01514.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 4.1] [Reference Citation Analysis]
75 Mas V, Maluf D, Archer K, Yanek K, Mas L, King A, Gibney E, Massey D, Cotterell A, Fisher R. Establishing the molecular pathways involved in chronic allograft nephropathy for testing new noninvasive diagnostic markers. Transplantation. 2007;83:448-457. [PMID: 17318078 DOI: 10.1097/01.tp.0000251373.17997.9a] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 3.9] [Reference Citation Analysis]
76 Mas VR, Mas LA, Archer KJ, Yanek K, King AL, Gibney EM, Cotterell A, Fisher RA, Posner M, Maluf DG. Evaluation of gene panel mRNAs in urine samples of kidney transplant recipients as a non-invasive tool of graft function. Mol Med 2007;13:315-24. [PMID: 17622313 DOI: 10.2119/2007–00017.Mas] [Cited by in Crossref: 23] [Article Influence: 1.5] [Reference Citation Analysis]
77 Webster AC, Lee VW, Chapman JR, Craig JC. Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation. 2006;81:1234-1248. [PMID: 16699448 DOI: 10.1097/01.tp.0000219703.39149.85] [Cited by in Crossref: 257] [Cited by in F6Publishing: 222] [Article Influence: 16.1] [Reference Citation Analysis]
78 Cotiguala L, Masood A, Park JM, Samaniego-Picota MD, Kaul DR, Naik AS. Increasing net immunosuppression after BK polyoma virus infection. Transpl Infect Dis 2021;23:e13472. [PMID: 32959930 DOI: 10.1111/tid.13472] [Reference Citation Analysis]
79 Seron D, Moreso F, Arias M, Campistol JM, Curto J, Hernandez D, Morales JM, Sanchez-Fructuoso A, Abraira V; Spanish Late Allograft Dysfunction Study Group. Estimation of renal allograft half-life: fact or fiction? Nephrol Dial Transplant 2011;26:3013-8. [PMID: 21292814 DOI: 10.1093/ndt/gfq788] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
80 Gaston RS. Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm. Clin J Am Soc Nephrol 2009;4:2029-34. [PMID: 19850771 DOI: 10.2215/CJN.03820609] [Cited by in Crossref: 88] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
81 Israni AK, Leduc R, Jacobson PA, Wildebush W, Guan W, Schladt D, Matas AJ, Oetting WS; DeKAF Genomics Investigators. Inflammation in the setting of chronic allograft dysfunction post-kidney transplant: phenotype and genotype. Clin Transplant 2013;27:348-58. [PMID: 23350966 DOI: 10.1111/ctr.12074] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
82 Legendre C, Brault Y, Morales JM, Oberbauer R, Altieri P, Riad H, Mahony J, Messina M, Pussell B, Martínez JG. Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus-based therapy: a multivariate analysis of results at five years. Clin Transplant. 2007;21:330-336. [PMID: 17488381 DOI: 10.1111/j.1399-0012.2007.00645.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]